West Pharmaceutical Services (WST) Revenue — Quarter Ended Sep 30, 2025
Revenue for the reported quarter increased compared to both the prior quarter and the same quarter last year. This marks a continuation of the upward trend seen in recent quarters.
Key takeaway
Quarter ended Sep 30, 2025 · FY2025 Q3
Revenue for the reported quarter increased compared to both the prior quarter and the same quarter last year. This marks a continuation of the upward trend seen in recent quarters.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$804.6M
Revenue reported for this quarter.
Quarter-over-quarter
+5.0%
Change from the immediately preceding quarter.
Year-over-year
+7.7%
Change from the comparable year-ago quarter.
Trailing four quarters
$3B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2024 | $748.8M | +2.3% |
| Mar 31, 2025 | $698M | +0.4% |
| Jun 30, 2025 | $766.5M | +9.2% |
| Sep 30, 2025 | $804.6M | +7.7% |
Revenue performance
The company reported higher net sales for the quarter, reflecting an increase from the prior period.
Quarterly comparison
Compared to the immediately preceding quarter, revenue rose sequentially. When compared to the same quarter one year earlier, revenue also showed a year-over-year increase.
What to watch
The sequential revenue growth trailed the year-over-year growth rate, a trend worth watching.